Vimarsana
Biggest News Aggregation in the World

Page 42 - Outlayer Item News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Outlayer Item. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Outlayer Item Today - Breaking & Trending Today

Peering into the future of PAH treatment - Vimarsana News

Peering into the future of PAH treatment

As understanding of pulmonary arterial hypertension grows and novel therapies emerge, the treatment of PAH appears to be entering a new era. “There have been a lot of new developments in therapy that have grown out of the extensive research that has been applied to this condition over the past several decades, and everything that we’ve learned up until now is coming to bear,”

Source: healio.com
Association found between severe visual impairment, overall poorer health - Vimarsana News

Association found between severe visual impairment, overall poorer health

Populations with severe visual impairment were found to have more physically unhealthy days as compared with their nonvisually impaired counterparts, according to data published in Optometry and Vision Science.“Because vision impairment does not typically result in physical pain, physically unhealthy days represents a useful surrogate to characterize the overall health of the population

Source: healio.com
Patients report satisfaction with EDOF lens despite optical phenomena - Vimarsana News

Patients report satisfaction with EDOF lens despite optical phenomena

A diffractive extended depth of focus IOL helped improve visual acuity at 3 months after bilateral implantation, according to research presented at the European Society of Cataract and Refractive Surgeons meeting. Thomas Kohnen, MD, presented data from a study that evaluated visual performance after bilateral implantation of the extended depth of focus (EDOF) At Lara 829MP lens (Carl Zeiss

Source: healio.com
IAMI - Vimarsana News

IAMI

Cardiology Today | Influenza vaccine vs. saline placebo administered shortly after MI or hospitalization for high-risk stable CAD.

Source: healio.com
Limbix announces smartphone tool for treating youth depression - Vimarsana News

Limbix announces smartphone tool for treating youth depression

Prescription digital therapeutic company Limbix announced the launch of a digital tool for teens and young adults with depression symptoms. The therapeutic, SparkRx, incorporates cognitive behavioral therapy and is meant to serve as an adjunct treatment for individuals aged 13 to 22 years.

Source: healio.com